Multicenter Phase 2 Study of Peri-Irradiation Chemotherapy Plus Intensity Modulated Radiation Therapy With Concurrent Weekly Docetaxel for Inoperable or Medically Unresectable Nonmetastatic Gastric Cancer

International Journal of Radiation Oncology, Biology, Physics, Volume 98, Issue 5, 2017 Aug 1 | Liu, Yong, MD; Zhao, Guoqi, MD; Xu, Yi, MD;...
Summary This report describes that a novel regimen consisting of concurrent docetaxel-based chemoradiation therapy using intensity modulated radiation therapy (50.4 Gy) in combination with preradiation and postradiation chemotherapy (docetaxel, ci...

http://ift.tt/2vgC93h